Facebook Twitter YouTube LinkedIn Reddit

Awakn Life Sciences Corp.

Disclaimer: All stock information on InvestorIntel.com is currently being fed from multiple sources and is updated automatically every 10-minutes. The information on this site is for information purposes only and InvestorIntel Corp. is neither responsible nor liable for the accuracy of this data.

InvestorIntel Features on Awakn Life Sciences Corp.

Awakn Life Sciences’ new psychedelic drug treatment for alcohol addiction moving to clinical trial

As we all know alcohol addiction is one of the worst addictions in society costing billions per year. A 2010 […]

Awakn announces first-ever study investigating ketamine in gambling addiction treatment

When we think about addiction many people think about drugs, tobacco, and alcohol addiction; but often forget about gambling addiction. […]

Awakn researching psychedelics for a better future

Whether you are familiar with it or not there have been relatively rapid advancements in health care and research utilizing […]

Company Overview

Team | Website

Awakn Life Sciences is a biotechnology company with clinical operations, developing and delivering psychedelic therapeutics (medicines and therapies) to better treat addiction. Awakn’s team consists of world leading chemists, scientists, psychiatrists, and psychologists who are developing and advancing the next generation of psychedelic drugs, therapies, and enabling technologies to treat addiction. Awakn will deliver these evidence backed psychedelic therapies in clinics in the UK and Europe and through licensing partnerships globally.

News Releases

View All News

Facebook Twitter YouTube LinkedIn Reddit